{
  "trial_id": "NCT01266031",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "histologically proven glioblastoma, gliosarcoma or anaplastic glioma",
      "label": "met",
      "evidence": "Patient has a history of anaplastic astrocytoma of the spine."
    },
    {
      "criterion": "age 18 years old or older",
      "label": "met",
      "evidence": "Patient is a 45-year-old man."
    },
    {
      "criterion": "Karnofsky performance status (KPS) equal or greater than 60",
      "label": "unknown",
      "evidence": "No information provided about KPS."
    }
  ],
  "exclusion": [
    {
      "criterion": "prior treatment with bevacizumab or Vorinostat",
      "label": "does_not_trigger",
      "evidence": "No mention of prior treatment with bevacizumab or Vorinostat."
    },
    {
      "criterion": "history of any other cancer (except non-melanoma skin cancer or carcinoma in-situ of the cervix or bladder)",
      "label": "unknown",
      "evidence": "Patient has a history of anaplastic astrocytoma, but it is unclear if this meets the exclusion criteria."
    },
    {
      "criterion": "inadequately controlled hypertension (defined as systolic blood pressure > 140 mmHg and/or diastolic blood pressure > 90 mmHg)",
      "label": "unknown",
      "evidence": "No information provided about patient's blood pressure."
    }
  ],
  "notes": "Patient has a history of anaplastic astrocytoma, but it is unclear if this meets the exclusion criteria for other cancers. Additionally, there is no information provided about KPS or blood pressure.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT01266031",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b"
  }
}